JAMJOOM PHARMACEUTICALS FACTORY TADAWUL:4015:
JAMJOOM PHARMA Q3 NET PROFIT SAR 106.67 MILLION
JAMJOOM PHARMA Q3 SALES SAR 342.31 MILLION
Jamjoom Pharma Q3 Profit SAR 106.67 Million
Jamjoom Pharmaceuticals Factory Co. on 6ix
In the deck
Earlier from Jamjoom Pharmaceuticals Factory
- PRESSR: Jamjoom Pharma unveils new brand identity
- PRESSR: Jamjoom Pharma unveils new brand identity to accelerate regional and global growth
- PRESSR: Jamjoom Pharma and Iraqi Dermatology Society sign MoU to transform skin health awareness
- SNG: Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA
- Jamjoom Pharma Strikes Strategic Deal With Bio-Thera For Securing Cosentyx Biosimilar In MENA
Later from Jamjoom Pharmaceuticals Factory
- SNG: Saudi: Jamjoom Pharma’s net profits near $105.6mln in 9M-25
- PRESSR: Lifera and Jamjoom Pharma launch strategic joint venture to power Saudi Arabia’s biopharma future
- SNG: Jamjoom Pharma, PIF-backed Lifera launch JV to strengthen Saudi biopharma manufacturing ecosystem
- ZAWYA-PRESSR: Jamjoom Pharma Egypt signs cooperation protocol with Research Institute of Ophthalmology
- Jamjoom Pharma H2 Dividend SAR 2 /Share
Follow Jamjoom Pharmaceuticals Factory into a list and get an email when it puts out news.
Follow Jamjoom Pharmaceuticals Factory